James C. Richards
Direktor/Vorstandsmitglied bei SYMBOLLON PHARMACEUTICALS INC.
Profil
James C.
Richards is currently the President, Chief Executive Officer & Director at Biocide Pharma, Inc. since 2011.
He is also an Independent Director at Symbollon Pharmaceuticals, Inc. since 1991.
Previously, he served as the President, Chief Executive Officer & Director at EdgeLight BioScience, Inc. from 2000 to 2008.
Prior to that, he was the Director-Business Planning & Development at Gene Trak Systems in 1990.
Aktive Positionen von James C. Richards
| Unternehmen | Position | Beginn |
|---|---|---|
| SYMBOLLON PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.05.1991 |
Biocide Pharma, Inc.
 Biocide Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biocide Pharma, Inc. operates as a pharmaceutical company. The private company is based in Sudbury, MA. James C. Richards has been the CEO of the company since 2008. | Vorstandsvorsitzender | 11.12.2009 |
Ehemalige bekannte Positionen von James C. Richards
| Unternehmen | Position | Ende |
|---|---|---|
| EdgeLight BioScience, Inc. | Präsident | 01.11.2008 |
Gene Trak Systems
 Gene Trak Systems Medical SpecialtiesHealth Technology Part of Neogen Corp., Gene Trak Systems is an American company that provides food testing services using innovative DNA probe-based products for bacterial contaminants. Gene Trak Systems was acquired by Neogen Corp. from Abbott Molecular, Inc. on August 06, 2001 for $3.50 million. | Corporate Officer/Principal | 01.01.1990 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Symbollon Pharmaceuticals, Inc.
 Symbollon Pharmaceuticals, Inc. BiotechnologyHealth Technology Symbollon Pharmaceuticals, Inc. develops and sells pharmaceutical products based on iodine technology. The company was founded by Jack H. Kessler in July 1986 and is headquartered in Medfield, MA. | Health Technology |
Gene Trak Systems
Gene Trak Systems Medical SpecialtiesHealth Technology Part of Neogen Corp., Gene Trak Systems is an American company that provides food testing services using innovative DNA probe-based products for bacterial contaminants. Gene Trak Systems was acquired by Neogen Corp. from Abbott Molecular, Inc. on August 06, 2001 for $3.50 million. | Health Technology |
| EdgeLight BioScience, Inc. | |
Biocide Pharma, Inc.
Biocide Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biocide Pharma, Inc. operates as a pharmaceutical company. The private company is based in Sudbury, MA. James C. Richards has been the CEO of the company since 2008. | Health Technology |
